Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
Shore N, Gazi M, Pieczonka C, Heron S, Modh R, Cahn D, Belkoff LH, Berger A, Mazzarella B, Veys J, Idom C, Morris D, Jayram G, Engelman A, Bukkapatnam R, Dato P, Bevan-Thomas R, Cornell R, Wise DR, Hardwick MK, Hernandez RD, Rojahn S, Layman P, Hatchell KE, Heald B, Nussbaum RL, Nielsen SM, Esplin ED. Shore N, et al. Among authors: esplin ed. Eur Urol Oncol. 2023 Oct;6(5):477-483. doi: 10.1016/j.euo.2023.07.008. Epub 2023 Aug 12. Eur Urol Oncol. 2023. PMID: 37574391 Free article.
Real-World Genetic Testing Utilization Among Patients With Cardiomyopathy.
Morales A, Moretz C, Ren S, Smith E, Callis TE, Hall T, Hatchell KE, Nussbaum RL, Regalado E, Rojahn S, Vatta M, Esplin ED, Murillo J. Morales A, et al. Among authors: esplin ed. Circ Genom Precis Med. 2024 Feb;17(1):e004028. doi: 10.1161/CIRCGEN.122.004028. Epub 2023 Dec 13. Circ Genom Precis Med. 2024. PMID: 38088168 No abstract available.
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
Jones JC, Golafshar MA, Coston TW, Rao R, Wysokinska E, Johnson E, Esplin ED, Nussbaum RL, Heald B, Klint M, Barrus K, Uson PL Jr, Nguyen CC, Colon-Otero G, Bekaii-Saab TS, Dronca R, Kunze KL, Samadder NJ. Jones JC, et al. Among authors: esplin ed. Cureus. 2023 Apr 11;15(4):e37428. doi: 10.7759/cureus.37428. eCollection 2023 Apr. Cureus. 2023. PMID: 37181954 Free PMC article.
Racial disparities in cascade testing for cancer predisposition genes.
Kassem NM, Althouse SK, Monahan PO, Hayes L, Nielsen SM, Heald B, Esplin ED, Hatchell KE, Ballinger TJ. Kassem NM, et al. Among authors: esplin ed. Prev Med. 2023 Jul;172:107539. doi: 10.1016/j.ypmed.2023.107539. Epub 2023 May 6. Prev Med. 2023. PMID: 37156429
Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
Abdel-Razeq H, Al-Azzam K, Elemian S, Abu-Fares H, Abu Sheikha A, Bani Hani H, Bater R, Sharaf B, Heald B, Esplin ED, Nielsen SM, Alkyam M, Abujamous L, Al-Attary A. Abdel-Razeq H, et al. Among authors: esplin ed. Mol Genet Genomic Med. 2023 Apr;11(4):e2125. doi: 10.1002/mgg3.2125. Epub 2022 Dec 19. Mol Genet Genomic Med. 2023. PMID: 36537080 Free PMC article.
107 results